Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07217873 · ClinicalTrials.gov registry record · Phase 2
IntraVenous Iron in Kids With Iron Deficiency and Scoliosis Study
A Phase 2 study of Spinal Fusion and Iron-deficiency, sponsored by Columbia University.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT07217873 is a Phase 2 study of Spinal Fusion and Iron-deficiency that is actively recruiting participants, run by Columbia University. The registered enrollment target is 120 participants, below the 477-participant average among 19 other Spinal Fusion trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07217873, a Phase 2 study of Spinal Fusion and Iron-deficiency, is actively recruiting participants, sponsored by Columbia University.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
Adolescents and young adults undergoing spinal fusion surgery for the correction of scoliosis and other spinal deformity are at high risk of perioperative iron deficiency and anemia, yet the means and evidence for optimizing iron status have not been described in this setting. The proposed study is a randomized controlled trial of preoperative intravenous iron supplementation, to identify whether iron deficiency is a modifiable risk factor for adverse surgical outcomes such as red blood cell transfusion and diminished postoperative cognitive and physical capacity in this vulnerable population. Building evidence for patient blood management interventions such as iron supplementation is vital to ensuring high quality care of surgical patients and may reduce unnecessary transfusions amid recent blood shortages.
Conditions Studied
Interventions
- DRUG Normal Saline (Placebo)
- DRUG Ferric carboxymaltose IV
Study Locations (1)
New York
- Columbia University Irving Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2025-11-21 |
| Est. Completion | 2027-10-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07217873
The ClinicalTrials.gov registry entry for NCT07217873 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 477-participant average among 19 other Spinal Fusion trials with a reported enrollment target (75% lower). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 7 conditions, with Spinal Fusion appearing as the primary indexed condition, and to 2 interventions - of which Normal Saline (Placebo) is the first listed.
NCT07217873 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT07217873 about?
NCT07217873 is a clinical study titled "IntraVenous Iron in Kids With Iron Deficiency and Scoliosis Study". Adolescents and young adults undergoing spinal fusion surgery for the correction of scoliosis and other spinal deformity are at high risk of perioperative iron deficiency and anemia, yet the means and evidence for optimizing iron status have not been described in this setting. The proposed study is ...
What is the current status of trial NCT07217873?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 120 participants. The study started on 2025-11-21. Estimated completion is 2027-10-31.
What conditions does trial NCT07217873 study?
This clinical trial studies the following conditions: Spinal Fusion, Iron-deficiency, Surgery--Complications, Scoliosis Correction, Transfusion Blood.
What interventions are being tested in trial NCT07217873?
The interventions under investigation include: Normal Saline (Placebo) (DRUG), Ferric carboxymaltose IV (DRUG).
Who is sponsoring clinical trial NCT07217873?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07217873 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Fusion
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery
RECRUITING · Phase 2
-
A Clinical Trial of Intravenous Lidocaine After Spinal Surgery to Prevent Delirium and Reduce Pain
RECRUITING · Phase 3
-
Pulse-Width Modulation
RECRUITING · NA
-
Durability of Suppl. Rod Constructs-SuppleMentAry Rod Technique for Long-segment Posterior Instrumented Spinal Fusions
RECRUITING
-
Photobiomodulation for Lower Back Pain Post Spinal Fusion and Decompression Surgery
RECRUITING · NA
-
Kids With Iron Deficiency and Scoliosis
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.